𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Hormonally induced differentiation: A novel approach to breast cancer prevention

✍ Scribed by José Russo; Irma H. Russo

Book ID
102878931
Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
635 KB
Volume
59
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

✦ Synopsis

Breast cancer, one of the most common neoplasms in women, develops more frequently in those who are nulliparous or late parous, who experience early menarche and late menopause and have a family history of breast cancer. Early parity, late menarche, early menopause, and hormone deprivation exert a protective effect. The mechanisms modulating these variations in malignancy susceptibility are not known. Epidemiologic and experimental studies indicate that malignancies develop in the mam-

📜 SIMILAR VOLUMES

Hormonal approach to breast cancer preve
Hormonal approach to breast cancer prevention
✍ Irma H. Russo; Jose Russo 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB 👁 2 views

Breast cancer is more frequent in nulliparous women, while its incidence is significantly reduced by full-term pregnancy. The fact that the protection conferred by pregnancy is observed in women from different countries and ethnic groups, regardless of the endogenous incidence of this malignancy, in

Pharmacological inhibition of fatty acid
Pharmacological inhibition of fatty acid synthase (FAS): A novel therapeutic approach for breast cancer chemoprevention through its ability to suppress Her-2/neu (erbB-2) oncogene-induced malignant transformation
✍ Javier A. Menendez; Inderjit Mehmi; Vishal A. Verma; Poh K. Teng; Ruth Lupu 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 631 KB

## Abstract We designed our experiments to evaluate whether fatty acid synthase (FAS), a lipogenic enzyme linked to tumor virulence in population studies of human cancer, is necessary for the malignant transformation induced by Her‐2/neu (erbB‐2) oncogene, which is overexpressed not only in invasiv

Hypoxia inducible factor-1α is a prognos
Hypoxia inducible factor-1α is a prognostic marker in premenopausal patients with intermediate to highly differentiated breast cancer but not a predictive marker for tamoxifen response
✍ Åsa Kronblad; Karin Jirström; Lisa Rydén; Bo Nordenskjöld; Göran Landberg 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 765 KB

## Abstract Hypoxia is common in many solid tumours, including breast cancer. Hypoxia triggers the expression of hypoxia inducible factor‐1α (HIF‐1α), and HIF‐1α has been associated with an impaired prognosis in breast cancer and down‐regulation of the oestrogen receptor (ER), potentially affecting

Quantitative analysis of follicle-stimul
Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: A novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems
✍ Jun Wang; Lynne Lin; Vinita Parkash; Peter E. Schwartz; Stuart C. Lauchlan; Wenx 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 201 KB

## Abstract The role of FSHR expression in ovarian cancer development is not clear. We examined quantitative expression of FSHR in different types of OET, presumed precursor lesions and peritoneal implants and further discussed FSH as a key growth‐promotion factor for the process of ovarian epithel